AD

N,1,4,4-Tetramethyl-8-{[4-(4-methyl-1-piperazinyl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide(CAS: 802539-81-7)

N,1,4,4-Tetramethyl-8-{[4-(4-methyl-1-piperazinyl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
CAS Number

Related Products

Other Suppliers for N,1,4,4-Tetramethyl-8-{[4-(4-methyl-1-piperazinyl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide

Basic Information

Molecular Formula
C25H32N8O
Molecular Weight
460.59 g/mol

Physical Properties

Density
1.33

Chemical Identifiers

SMILES
CC1(CC2=CN=C(N=C2C3=C1C(=NN3C)C(=O)NC)NC4=CC=C(C=C4)N5CCN(CC5)C)C
InChIKey
RXZMYLDMFYNEIM-UHFFFAOYSA-N

Database References

MDL Number
MFCD17169990

FAQ

N,1,4,4-Tetramethyl-8-{[4-(4-methyl-1-piperazinyl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide (CAS: 802539-81-7) falls under the purview of GHS (Globally Harmonized System of Classification and Labelling of Chemicals) for classification and labelling. It is also regulated by REACH (Registration, Evaluation, Authorization and Restriction of Chemicals) in the EU, requiring manufacturers and importers to register substances above a threshold of 1 tonne per year. FDA and EPA guidelines may apply based on its intended use, such as in pharmaceuticals or environmental applications.
Alternatives to N,1,4,4-Tetramethyl-8-{[4-(4-methyl-1-piperazinyl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide (CAS: 802539-81-7) include structurally similar derivatives such as analogs with different substituents or isomers. Common alternative reagents in synthesis include other quinazolines, piperazines, and methylated compounds. These alternatives can offer similar biological activity or chemical properties with varying synthesis complexity.
Research trends for N,1,4,4-Tetramethyl-8-{[4-(4-methyl-1-piperazinyl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide (CAS: 802539-81-7) focus on its potential as a pharmaceutical compound, particularly in treating neurological disorders and as an anti-inflammatory agent. Market trends indicate growing interest in its pharmacological applications, with increasing focus on optimizing its synthesis and pharmacokinetics.
Waste containing N,1,4,4-Tetramethyl-8-{[4-(4-methyl-1-piperazinyl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide (CAS: 802539-81-7) should be collected in appropriate containers and stored in a secure location away from ignition sources. Proper incineration or professional waste disposal methods should be utilized. Ensure that all handling and disposal procedures comply with local environmental protection regulations to prevent contamination of the environment.

Safety Notice

Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.

Always follow proper handling procedures

Contact Information

Email

info@atomaxchem.com

Mobile

13417589054